Clobazam
| Clobazam | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 300.74 g/mol [1] |
| Appearance | Crystals from 50% ethanol [1] |
| Taste | Slightly bitter taste [1] |
| Melting point | 182-185ºC [1] |
| Solubility | 188 mg/L [1] |
| Predicted LogP | 2.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H13ClN2O2 |
| IUPAC name | 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione |
| SMILES | CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3 |
| InChI | InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3 |
| InChIKey | CXOXHMZGEKVPMT-UHFFFAOYSA-N |
| CAS number | 22316-47-8 |
| UNII | 2MRO291B4U |
| PubChem CID | 2789 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 0.5–4 hours[3] |
| Elimination half-life | • Clobazam: 36–42 hours • N-desmethylclobazam: 71–82 hours[4] |
| Metabolism | Liver |
| Excretion | Kidney (82%), Feces (11%) |
| Routes of administration | By mouth, sublingual |
| Dependence liability | High |
| Addiction liability | High |
| Toxicity [] | |
|---|---|
| LD50 | Guinea: - pig oral: 109 mg/kg Rabbit: - oral: 320 mg/kg Rat: - ip: 740-1526 [1] |
Clobazam (also known as Frisium, Urbanyl, Clorepin, Urbadan, Onfi, Mystan, Lm-2717, Hr 376, Clobazamum or Caastilium) is a depressant substance of the aniline class.
Chemistry
Stereochemistry []
Clobazam is achiral.
Druglikeness
Lipinski's rule of five
Clobazam matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- anxiolytics (N05B)
- benzodiazepine derivatives (N05BA)
- (N05BA09)
- clobazam (N05BA09)
MeSH Classification
Mechanism of action []
The exact mechanism of action for clobazam, a 1,5-benzodiazepine, is not fully understood but is thought to involve the potentiation of GABAergic neurotransmission resulting from binding at the benzodiazepine site of the GABA<sub>A</sub> receptor. Specifically, clobazam binds to the interface of the α<sub>2</sub> and γ<sub>2</sub>-subunit of the GABA<sub>A</sub> receptor. It has a great affinity for the α<sub>2</sub> subunit than the α<sub>1</sub> subunit compared to other 1,4‐benzodiazepines.Binding of clobazam to the GABA<sub>A</sub> receptor causes chloride channels to open, resulting in an influx of chloride and thus hyperpolarization of neurons. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| CYP3A4 | metabolism / inhibition / induction | 769 |
|---|---|---|
| CYP2C19 | metabolism / inhibition / induction | 146 |
| GABRA1 | shared target | 52 |
| GABRA2 | shared target | 49 |
| GABRA3 | shared target | 49 |
| GABRA4 | shared target | 49 |
| GABRA5 | shared target | 49 |
| GABRA6 | shared target | 49 |
| GABRB1 | shared target | 49 |
| GABRB2 | shared target | 49 |
| GABRB3 | shared target | 49 |
| GABRD | shared target | 49 |
| GABRE | shared target | 49 |
| GABRG1 | shared target | 49 |
| GABRG2 | shared target | 49 |
| GABRG3 | shared target | 49 |
| GABRP | shared target | 49 |
| GABRQ | shared target | 49 |
Medical side effects []
100 side effects listed on drug labels in SIDER 4.1 (clobazam).
- Somnolence
- Body temperature increased
- Upper respiratory tract infection
- Drooling
- Lethargy
- Aggression
- Vomiting
- Ataxia
- Cough
- Asthenia
- Fatigue
- Irritability
- Insomnia
- Urinary tract infection
- Headache
- Depression
- Pneumonia
- Dry mouth
- Agitation
- Increased appetite
- Decreased appetite
- Anorexia
- Appetite absent
- Dysarthria
- Slurred speech
- Osteoarthritis
- Constipation
- Bronchitis
- Diarrhoea
- Nausea
- Tremor
- Tremor fine
- Hypotension
- Dysphagia
- Confusional state
- Feeling abnormal
- Dermatitis
- Rash
- Abdominal distension
- Anaemia
- Anxiety
- Mental disorder
- Delirium
- Delusion
- Diplopia
- Eosinophilia
- Eye disorder
- Gastrointestinal disorder
- Hallucination
- Blood disorder
- Leukopenia
- Muscle spasms
- Thrombocytopenia
- Urticaria
- Apathy
- Flat affect
- Skin disorder
- Respiratory depression
- Pulmonary function test decreased
- Hepatic enzyme increased
- Vision blurred
- Amnesia
- Asthma
- Abnormal behaviour
- Infection
- Libido decreased
- Disturbance in sexual arousal
- Dizziness
- Toxic epidermal necrolysis
- Hostility
- Nervous system disorder
- Nervousness
- Tension
- Nightmare
- Nystagmus
- Pruritus
- Psychotic disorder
- Respiratory failure
- Erythema multiforme
- Stevens-Johnson syndrome
- Hyperhidrosis
- Visual impairment
- Weight increased
- Drug withdrawal syndrome
- Liver function test abnormal
- Muscular weakness
- Malnutrition
- Hangover
- Myalgia
- Musculoskeletal discomfort
- Disorientation
- Anterograde amnesia
- Euphoric mood
- Drug dependence
- Musculoskeletal stiffness
- Balance disorder
- Dependence
- Infestation
- Suicidal behaviour
- Loss of libido
Indications
- Anxiety
- Brain injury
- Convulsion
- Epilepsy
- Lennox-Gastaut syndrome
- Sleep disturbance
Experience reports
Legal status []
- Australia: Clobazam is a Schedule 4.
- Brazil: Clobazam is a B1.[5]
- Canada: Clobazam is a Schedule IV.
- Germany: Clobazam is Prescription only/Anlage III.
- New Zealand: Clobazam is a Class C.
- United Kingdom: Clobazam is a Class C under the "Misuse of Drugs Act 1971".[6]
- United States: Clobazam is a Schedule IV under the "Controlled Substances Act".[7]
- United Nations: Clobazam is a Psychotropic Schedule IV.
- Other: Clobazam is a SE: Förteckning IV, In general: ℞ (Prescription only).[8]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2789, Clobazam. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2789
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Clobazam. UNII: 2MRO291B4U. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2MRO291B4U
Gauthier AC, Mattson RH. Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy. CNS Neuroscience & Therapeutics. July 2015; 21(7):543–548. PMID 25917225. https://doi.org/10.1111/cns.12399
Clobazam Monograph for Professionals. https://www.drugs.com/monograph/clobazam.html
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Frisium 10 mg Tablet Summary of Product Characteristics (SmPC). electronic medicines compendium (emc). 10 July 2025. https://www.medicines.org.uk/emc/product/100006/smpc
Onfi- clobazam tablet; Onfi- clobazam suspension. DailyMed. 12 March 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de03bd69-2dca-459c-93b4-541fd3e9571c
Klobazam. Läkemedelsverket.se. https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/substans/e4poepuae3tvert1/klobazam
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 16:32:33 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 16:32:29 |
| erowid | ok | 2026-11-20 16:32:31 |
| gsrs | ok | 2026-11-20 16:32:29 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014493) | 2026-11-20 16:32:29 |
| kegg | ok | 2026-11-20 16:32:34 |
| pubchem | ok | 2026-11-20 16:32:28 |
| missing (no r/tripreports posts mention it) | 2026-11-20 16:32:29 | |
| sider | ok | 2026-11-20 16:32:29 |
| structure | ok | 2026-11-20 16:32:29 |
| wikipedia | ok | 2026-11-20 16:32:29 |